Neurelis, INC.

Biopharmaceutical company specializing in treatments for neurological conditions.

Based in CA

🤖

AI Overview

With $80K in lobbying spend across 6 quarterly filings, Neurelis, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.

$80K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$30K
2025$50K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

  • Policy issues related to federal regulation of the healthcare industry.
  • Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (H.R. 7383 / S. 1214, 118th Congress).
  • Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
  • Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivit

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.